Glucophage Immediate Release (GIR) China Bioequivalence Study
Clinical trial NCT03393208 · COMPLETED
Trial details
- NCT number
- NCT03393208
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-10
- Primary completion
- 2018-01-29
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.